47.73.Z - Retail sale of pharmaceutical products
18 - Printing and reproduction of recorded media
20 - Manufacture of chemicals and chemical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
46 - Wholesale trade
47 - Retail trade
58 - Publishing activities
68 - Real estate activities
73 - Advertising, market research and public relations
86 - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0 | 0,1 | -0 | -112,5 |
Gross profit (loss) | -0 | 0,1 | 0 | -68,1 |
EBITDA | -0 | 0,1 | -0 | -100,1 |
Short time liabilities | 0,3 | 0,3 | 0,3 | 11,8 |
Other operating costs | 0 | 0 | 0 | -99,8 |
Equity capital | 0,3 | 0,4 | 0,4 | 7,1 |
Operating profit (EBIT) | -0 | 0,1 | -0 | -100,1 |
Assets | 0,6 | 0,7 | 0,8 | 9,2 |
Net profit (loss) | -0 | 0,1 | 0 | -64,4 |
Cash | 0,3 | 0,4 | 0,4 | -2,7 |
Liabilities and provisions for liabilities | 0,3 | 0,3 | 0,3 | 11,8 |
Net income from sale | 3 | 3,5 | 3,6 | 2,6 |
Working assets | 0,6 | 0,7 | 0,8 | 9,2 |
Other income costs | 0 | 0 | 0 | 1623,1 |
Depreciation | 0 | 0 | 0 | -100 |
% | % | % | p.p. | |
Profitability of capital | -11,7 | 20 | 6,6 | -13,4 |
Equity capital to total assets | 51,1 | 56,3 | 55,2 | -1,1 |
Gross profit margin | -1,3 | 2,5 | 0,8 | -1,7 |
EBITDA Margin | -0,6 | 2,5 | -0 | -2,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 37 | 32 | 35 | 3 |
Current financial liquidity indicator | 2.0370123386383057 | 2.2872273921966553 | 2.232945203781128 | -0,1 |
Net dept to EBITDA | 16.81075668334961 | -3.8149325847625732 | 3342.82958984375 | 3346,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane